The Dartmouth Institute for Health Policy & Clinical Practice Lebanon, New Hampshire.
Jacobs School of Medicine and Biomedical Sciences Buffalo, New York.
J Hosp Med. 2019 May;14(5):294-302. doi: 10.12788/jhm.3110.
Seriously ill people near death face difficult decisions about life-sustaining treatments such as cardiopulmonary resuscitation and mechanical ventilation. Patient decision aids may improve alignment between patients' preferences and the care they receive, but the quantity, quality, and routine use of these tools are unknown. We conducted a systematic environmental scan to identify all decision aids for seriously ill people at high risk of death facing choices about life-sustaining treatments, assess their quality, and explore their use in clinical settings. We searched MEDLINE, Google, and mobile application stores and surveyed experts. We included 27 decision aids in our scan. Concerning content, 14 of 27 decision aids for seriously ill people near death were for people with specific diseases and conditions (ie, advanced cancer or kidney disease); 11 concerned individual life-sustaining treatment decisions (ie, cardiopulmonary resuscitation or mechanical ventilation). Only two focused on more general care pathways (ie, life-sustaining intervention, palliative care, and hospice). Twenty-four of 27 decision aids presented options in a balanced way; 23 identified funding sources, and 19 of 27 reported their publication date. Just 11 used plain language. A minority, 11 of 27, listed evidence sources, five documented rigorous evidence-synthesis methods, six disclosed competing interests, and three offered update policies. Preliminary results suggest that few health systems use decision aids in routine patient care. Although many decision aids exist for life-sustaining treatment decisions during serious illness, the tools are deficient in some key quality areas.
生命垂危的重病患者在面临心肺复苏和机械通气等维持生命的治疗决策时,会面临艰难的抉择。患者决策辅助工具可以改善患者偏好与所接受治疗之间的一致性,但这些工具的数量、质量和常规使用情况尚不清楚。我们进行了系统的环境扫描,以确定所有面临维持生命的治疗决策选择的高死亡风险重病患者的决策辅助工具,评估其质量,并探索其在临床环境中的使用情况。我们在 MEDLINE、Google 和移动应用商店中进行了搜索,并调查了专家。我们在扫描中纳入了 27 种决策辅助工具。关于内容,27 种接近死亡的重病患者决策辅助工具中,有 14 种是针对特定疾病和病情(即晚期癌症或肾病)的患者;11 种涉及个人维持生命的治疗决策(即心肺复苏或机械通气)。只有两种关注更一般的护理途径(即维持生命的干预、姑息治疗和临终关怀)。27 种决策辅助工具中有 24 种以平衡的方式呈现了各种选择;23 种确定了资金来源,27 种中有 19 种报告了其出版日期。只有 11 种使用了通俗易懂的语言。少数(27 种中的 11 种)列出了证据来源,5 种记录了严格的证据综合方法,6 种披露了利益冲突,3 种提供了更新政策。初步结果表明,很少有卫生系统在常规患者护理中使用决策辅助工具。尽管有许多决策辅助工具可用于治疗严重疾病期间的维持生命的治疗决策,但这些工具在一些关键质量方面存在不足。